REG - IP Group PLC - Annual Financial Report

IPAnnouncement

Wed 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO4761Aa&default-theme=true

RNS Number : 4761A  IP Group PLC  15 April 2026

 FOR RELEASE ON  15 April 2026

IP Group - 2025 Annual Report

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which
invests in breakthrough science and innovation companies with the potential to
create a better future for all, announces that it has published its Annual
Report and Accounts for the year ended 31 December 2025.

 

In compliance with Listing Rule 9.6.3, a copy of the Annual Report and
Accounts for the year ended 31 December 2025 ("2025 ARA") will shortly be
available for inspection at
www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(http://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)
.

 

An electronic copy of the 2025 ARA is available on the Investor Relations
section of the IP Group website at www.ipgroupplc.com/investor-relations
(http://www.ipgroupplc.com/investor-relations) . Printed copies of the 2025
ARA are being posted to shareholders who have requested hard copies.

 

The Company's Annual General Meeting ("AGM") is scheduled to be held at 11.00
am on 18 June 2026 at the offices of the Company at 3 Pancras Square, King's
Cross, London, N1C 4AG, with refreshments available from 10.30 am. The Notice
of Meeting for the AGM together with the related proxy form and voting
instructions will be published separately in the coming weeks.

 

 

For more information, please contact:

 

 IP Group plc                       www.ipgroupplc.com
 Liz Vaughan-Adams, Communications  +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Alex Donaldson                     +44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most
active UK based, early stage science and technology investor, we develop and
support some of the world's most exciting businesses in healthtech, deeptech
and cleantech. Including through Parkwalk, the UK's largest growth EIS fund
manager, we back world-changing innovation emerging in leading universities
and research institutions. Our specialist investment team combines sector
expertise with an international approach. Together we have a strong track
record of success, having backed high-profile companies including Oxford
Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion,
Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock
Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSDZLFFQZLEBBE



            Copyright 2019 Regulatory News Service, all rights reserved